Outset Medical, Inc. (OM) Current Ratio
- Current ratio · latest quarter: Value 5.19×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 5.19× | Current assets / current liabilities. $227.85M ÷ $43.89M ≈ 5.19× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 227.85M USD | Assets, Current |
| Current obligations | 43.89M USD | Liabilities, Current |
| Cash and equivalents | 35.01M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Debt Securities, Available-for-sale, Current |
| Customer receivables | 29.22M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 47.31M USD | Inventory, Net |
| Payables | 4.46M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $227.85M | $43.89M | $35.01M | (m) | $29.22M | $47.31M | $4.46M | (m) | 5.19× |
| 2026-03-31 | $236.71M | $37.61M | $30.56M | (m) | $25.32M | $49.65M | $1.44M | (m) | 6.29× |
| 2025-12-31 | $250.88M | $37.63M | $35.01M | (m) | $28.33M | $47.61M | $554.00K | (m) | 6.67× |
| 2025-09-30 | $265.37M | $37.45M | $36.44M | (m) | $32.96M | $49.29M | $1.72M | (m) | 7.09× |
| 2025-06-30 | $275.58M | $36.91M | $39.56M | $66.75M | $34.89M | $52.25M | $1.45M | (m) | 7.47× |
| 2025-03-31 | $286.56M | $34.22M | $75.93M | $10.52M | $36.89M | $55.77M | $1.17M | (m) | 8.37× |
| 2024-12-31 | $258.22M | $45.38M | $124.01M | (m) | $35.62M | $59.39M | $3.86M | (m) | 5.69× |
| 2024-09-30 | $275.27M | $42.43M | $33.29M | $2.66M | $34.26M | $61.44M | $4.29M | (m) | 6.49× |
| 2024-06-30 | $295.14M | $43.43M | $37.86M | $130.13M | $34.12M | $61.60M | $5.25M | (m) | 6.80× |
| 2024-03-31 | $325.39M | $50.67M | $32.18M | $157.89M | $36.48M | $55.84M | $6.77M | (m) | 6.42× |
| 2023-12-31 | $291.22M | $55.32M | $68.51M | $64.88M | $32.98M | $49.22M | $5.83M | (m) | 5.26× |
| 2023-09-30 | $283.77M | $53.02M | $36.30M | $92.65M | $35.49M | $48.26M | $2.88M | (m) | 5.35× |
| 2023-06-30 | $309.40M | $48.82M | $36.39M | $138.82M | $36.90M | $44.49M | $2.22M | (m) | 6.34× |
| 2023-03-31 | $337.27M | $44.27M | $36.39M | $87.42M | $34.31M | $47.73M | $1.99M | (m) | 7.62× |
| 2022-12-31 | $373.64M | $51.95M | $73.22M | $154.53M | $28.07M | $51.48M | $603.00K | (m) | 7.19× |
| 2022-09-30 | $310.00M | $49.64M | $63.88M | (m) | $22.51M | $55.26M | $1.44M | (m) | 6.24× |
| 2022-06-30 | $345.78M | $55.24M | $75.50M | (m) | $24.63M | $53.69M | $2.75M | $1.00M | 6.26× |
| 2022-03-31 | $377.43M | $48.89M | $114.35M | (m) | $26.90M | $42.87M | $5.15M | (m) | 7.72× |
| 2021-12-31 | $409.80M | $51.70M | $182.35M | (m) | $25.60M | $39.19M | $1.76M | (m) | 7.93× |
| 2021-09-30 | $433.30M | $41.41M | $230.51M | (m) | $19.30M | $34.30M | $2.70M | (m) | 10.46× |
| 2021-06-30 | $447.96M | $35.44M | $274.27M | (m) | $16.41M | $28.88M | $2.36M | (m) | 12.64× |
| 2021-03-31 | $321.73M | $34.82M | $251.77M | (m) | $12.11M | $24.55M | $6.65M | (m) | 9.24× |
| 2020-12-31 | $345.91M | $36.69M | $294.97M | (m) | $6.47M | $18.38M | $4.95M | (m) | 9.43× |
| 2020-09-30 | $367.82M | $33.04M | $311.33M | (m) | $7.08M | $11.81M | $5.06M | (m) | 11.13× |
| 2019-12-31 | $79.65M | $24.91M | $36.93M | (m) | $3.91M | $4.60M | $4.96M | $7.50M | 3.20× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |